Showing results (61-70 of 451) with videos related to
Sort By:
Pageof 46
EMBO Reports|January 29, 2014
Ars Moriendi; the art of dying well - new insights into the molecular pathways of necroptotic cell deathJames M Murphy, John SilkeNature Reviews. Molecular Cell Biology|December 21, 2013
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapyPeter E Czabotar, Guillaume Lessene, Andreas Strasser, et al.Blood|February 24, 2007
Endogenous bcl-2 is not required for the development of Emu-myc-induced B-cell lymphomaPriscilla N Kelly, Hamsa Puthalakath, Jerry M Adams, et al.European Journal of Immunology|November 10, 2010
Apoptosis regulators Fas and Bim synergistically control T-lymphocyte homeostatic proliferationKaren A Fortner, Philippe Bouillet, Andreas Strasser, et al.International Immunology|May 17, 2003
Autoimmune kidney disease and lymphadenopathy in NODlpr mice are not modified by deficiency in tumor necrosis factor receptor 1 or beta 2-microglobulinTara Catterall, Dina Stockwell, Vikki Marshall, et al.Nature Reviews. Cancer|April 4, 2009
Unleashing the power of inhibitors of oncogenic kinases through BH3 mimeticsMark S Cragg, Claire Harris, Andreas Strasser, et al.Apoptosis : an International Journal on Programmed Cell Death|November 7, 2022
BCL-2 protein family: attractive targets for cancer therapyDeeksha Kaloni, Sarah T Diepstraten, Andreas Strasser, et al.Current Cancer Drug Targets|March 14, 2008
Ubiquitylation and cancer developmentMaria Miasari, Hamsa Puthalakath, John SilkePageof 46